G3T is a Midlothian, Virginia-based biotechnology company developing genetically validated therapeutics and diagnostics using genomics, panomic profiling, and AI/ML. For fundraising relevance, it is best treated as a strategic or non-traditional investor candidate with Germany-linked later-stage VC activity and aerospace and space exposure, rather than as a dedicated venture fund.